Ultragenyx Pharmaceutical Inc. buy Evercore ISI
Start price
06.06.23
/
50%
€48.20
Target price
06.06.24
€74.95
Performance (%)
-21.16%
Price
13.05.24
€38.00
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -21.16%. This prediction currently runs until 06.06.24. The prediction end date can be changed by Evercore_ISI at any time. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -5.000% | -5.000% |
| iShares Core DAX® | 2.749% | 4.620% |
| iShares Nasdaq 100 | 0.470% | -0.331% |
| iShares Nikkei 225® | -2.930% | -5.556% |
| iShares S&P 500 | 0.679% | 0.631% |
Comments by Evercore_ISI for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $80.00 price target on the stock, up previously from $60.00.
Ratings data for RARE provided by MarketBeat